Human induced pluripotent stem cells (hiPSCs) are considered a promising tool in medicine, with the potential to unlock ...
Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a ...